Jazz Pharmaceuticals (JAZZ) Change in Taxes (2012 - 2026)

Jazz Pharmaceuticals has reported Change in Taxes for 15 years, with the latest figure at $37.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Taxes rose 187.69% year-over-year to $37.4 million; the trailing twelve-month figure through Mar 2026 stood at $61.6 million (up 471.23% YoY), and the FY2025 full-year result was $37.2 million, up 352.5% from the prior year.
• Change in Taxes for Q1 2026 stood at $37.4 million, up from -$34.8 million in the prior quarter.
• The five-year high for Change in Taxes was $46.3 million in Q2 2025, with the low at -$35.9 million in Q4 2023.
• Average Change in Taxes over 5 years is $4.9 million, with a median of $12.7 million recorded in 2025.
• Year-over-year, Change in Taxes tumbled 2264.41% in 2023 and soared 1358.7% in 2025.
• Tracing JAZZ's Change in Taxes over 5 years: stood at -$1.5 million in 2022, then plunged by 2264.41% to -$35.9 million in 2023, then increased by 3.06% to -$34.8 million in 2024, then grew by 0.16% to -$34.8 million in 2025, then surged by 207.52% to $37.4 million in 2026.
• The last three Change in Taxes figures came in at $37.4 million (Q1 2026), -$34.8 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.

Peer Comparison